OpenURL Connection Search

Select item for more details and to access through your institution.

Utility of laboratory tests in B-CLL patients in different clinical stages.
Published in:
2011
By:
- Rusak, Małgorzata;
- Osada, Joanna;
- Pawlus, Joanna;
- Chociej-Stypułkowska, Joanna;
- Dąbrowska, Milena;
- Kłoczko, Janusz;
- Rusak, Małgorzata;
- Chociej-Stypułkowska, Joanna;
- Dąbrowska, Milena;
- Kłoczko, Janusz
Publication type:
journal article
Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.
Published in:
Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0643-z
By:
- Sellers, Zachariah Payne;
- Bolkun, Lukasz;
- Kloczko, Janusz;
- Wojtaszewska, Marzena Liliana;
- Lewandowski, Krzysztof;
- Moniuszko, Marcin;
- Ratajczak, Mariusz Z.;
- Schneider, Gabriela
Publication type:
Article
Very Small Embryonic-Like Stem Cells, Endothelial Progenitor Cells, and Different Monocyte Subsets Are Effectively Mobilized in Acute Lymphoblastic Leukemia Patients after G-CSF Treatment.
Published in:
Stem Cells International, 2018, p. 1, doi. 10.1155/2018/1943980
By:
- Eljaszewicz, Andrzej;
- Bolkun, Lukasz;
- Grubczak, Kamil;
- Rusak, Malgorzata;
- Wasiluk, Tomasz;
- Dabrowska, Milena;
- Radziwon, Piotr;
- Marlicz, Wojciech;
- Kamiński, Karol;
- Kloczko, Janusz;
- Moniuszko, Marcin
Publication type:
Article
The levels of sMUC-1 in patients with multiple myeloma.
Published in:
Folia Histochemica et Cytobiologica, 2011, v. 49, n. 4, p. 654, doi. 10.5603/FHC.2011.0089
By:
- Lemancewicz, Dorota;
- Bolkun, Lukasz;
- Porowska, Halina;
- Galar, Marzenna;
- Semeniuk, Janusz;
- Kloczko, Janusz;
- Dzieciol, Janusz
Publication type:
Article
Assessment of expression of selected Bcl-2 family proteins in lymphoid infiltration in patients with B-cell chronic lymphocytic leukaemia treated with nucleoside analogues.
Published in:
Folia Histochemica et Cytobiologica, 2008, v. 46, n. 3, p. 361, doi. 10.2478/v10042-008-0053-0
By:
- Lemancewicz, Dorota;
- Dzięcioł, Janusz;
- Piszcz, Jarosław;
- Lebelt, Agnieszka;
- Mazgajska-Barczyk, Katarzyna;
- Klim, Beata;
- Kłoczko, Janusz
Publication type:
Article
A five‐year follow‐up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial.
Published in:
British Journal of Haematology, 2020, v. 190, n. 5, p. 736, doi. 10.1111/bjh.16625
By:
- Offner, Fritz;
- Robak, Tadeusz;
- Janssens, Ann;
- Govind Babu, K.;
- Kloczko, Janusz;
- Grosicki, Sebastian;
- Mayer, Jiri;
- Panagiotidis, Panagiotis;
- Schuh, Anna;
- Pettitt, Andrew;
- Montillo, Marco;
- Werner, Olena;
- Vincent, Ghislaine;
- Khanna, Sadhvi;
- Hillmen, Peter
Publication type:
Article
A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial.
Published in:
British Journal of Haematology, 2019, v. 185, n. 4, p. 691, doi. 10.1111/bjh.15824
By:
- Gisslinger, Heinz;
- Buxhofer‐Ausch, Veronika;
- Hodisch, Juri;
- Radinoff, Atanas;
- Karyagina, Elena;
- Kyrcz‐Krzemień, Slawomira;
- Abdulkadyrov, Kudrat;
- Gerbutavicius, Rolandas;
- Melikyan, Anait;
- Burgstaller, Sonja;
- Hus, Marek;
- Kłoczko, Janusz;
- Yablokova, Vera;
- Tzvetkov, Nikolay;
- Całbecka, Malgorzata;
- Shneyder, Tatyana;
- Warzocha, Krzysztof;
- Jurgutis, Mindaugas;
- Kaplanov, Kamil;
- Jilma, Bernd
Publication type:
Article
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2017, v. 176, n. 4, p. 618, doi. 10.1111/bjh.14464
By:
- Robak, Tadeusz;
- Hellmann, Andrzej;
- Kloczko, Janusz;
- Loscertales, Javier;
- Lech ‐ Maranda, Ewa;
- Pagel, John M.;
- Mato, Anthony;
- Byrd, John C.;
- Awan, Farrukh T.;
- Hebart, Holger;
- Garcia ‐ Marco, Jose A.;
- Hill, Brian T.;
- Hallek, Michael;
- Eisenfeld, Amy J.;
- Stromatt, Scott C.;
- Jaeger, Ulrich
Publication type:
Article
High chymotrypsin-like activity in the plasma of patients with newly diagnosed multiple myeloma treated with bortezomib is predictive of a better response and longer PFS.
Published in:
2018
By:
- Romaniuk, Wioletta;
- Bolkun, Lukasz;
- Galar, Marzenna;
- Bernatowicz, Malgorzata;
- Kloczko, Janusz;
- Kalita, Joanna;
- Ostrowska, Halina
Publication type:
journal article
The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age.
Published in:
Cancers, 2023, v. 15, n. 13, p. 3469, doi. 10.3390/cancers15133469
By:
- Tyczyńska, Agata;
- Krzempek, Marcela Krzysława;
- Cortez, Alexander Jorge;
- Jurczyszyn, Artur;
- Godlewska, Katarzyna;
- Ciepłuch, Hanna;
- Subocz, Edyta;
- Hałka, Janusz;
- Kulikowska de Nałęcz, Anna;
- Wiśniewska, Anna;
- Świderska, Alina;
- Waszczuk-Gajda, Anna;
- Drozd-Sokołowska, Joanna;
- Guzicka-Kazimierczak, Renata;
- Wiśniewski, Kamil;
- Porowska, Agnieszka;
- Knopińska-Posłuszny, Wanda;
- Kłoczko, Janusz;
- Rzepecki, Piotr;
- Woszczyk, Dariusz
Publication type:
Article
Prognostic relevance of HSP70 antigen and antibody measurement in patients with acute myeloid leukemia of intermediate and unfavorable cytogenetic risk.
Published in:
Polish Archives of Internal Medicine, 2014, v. 124, n. 4, p. 165, doi. 10.20452/pamw.2184
By:
- Piszcz, Jarosław;
- Bolkun, Łukasz;
- Cichocka, Edyta;
- Galar, Marzenna;
- Hołownia, Adam;
- Kłoczko, Janusz
Publication type:
Article
Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG ‐ CLL4 (ML21283) trial.
Published in:
European Journal of Haematology, 2018, v. 100, n. 5, p. 465, doi. 10.1111/ejh.13042
By:
- Robak, Tadeusz;
- Błoński, Jerzy;
- Skotnicki, Aleksander Bartłomiej;
- Piotrowska, Magdalena;
- Wróbel, Tomasz;
- Rybka, Justyna;
- Kłoczko, Janusz;
- Bołkun, Łukasz;
- Budziszewska, Bożena Katarzyna;
- Walczak, Urszula;
- Uss, Anatoly;
- Fidecka, Marta;
- Smolewski, Piotr
Publication type:
Article
Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil - follow-up of PALG- CLL randomized trials.
Published in:
European Journal of Haematology, 2013, v. 91, n. 1, p. 1, doi. 10.1111/ejh.12112
By:
- Blonski, Jerzy Z.;
- Robak, Tadeusz;
- Chojnowski, Krzysztof;
- Gora‐Tybor, Joanna;
- Warzocha, Krzysztof;
- Ceglarek, Bernadetta;
- Seferynska, Ilona;
- Calbecka, Malgorzata;
- Kostyra, Aleksandra;
- Stella‐Holowiecka, Beata;
- Kloczko, Janusz;
- Dmoszynska, Anna;
- Kowal, Malgorzata;
- Lewandowski, Krzysztof;
- Dwilewicz‐Trojaczek, Jadwiga;
- Wiater, Elzbieta;
- Kuliczkowski, Kazimierz;
- Potoczek, Stanislaw;
- Hellmann, Andrzej;
- Mital, Andrzej
Publication type:
Article
Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group
Published in:
European Journal of Haematology, 2008, v. 80, n. 2, p. 115, doi. 10.1111/j.1600-0609.2007.00988.x
By:
- Wierzbowska, Agnieszka;
- Robak, Tadeusz;
- Pluta, Agnieszka;
- Wawrzyniak, Ewa;
- Cebula, Barbara;
- Hołowiecki, Jerzy;
- Kyrcz-Krzemień, Sławomira;
- Grosicki, Sebastian;
- Giebel, Sebastian;
- Skotnicki, Aleksander B.;
- Piątkowska-Jakubas, Beata;
- Kuliczkowski, Kazimierz;
- Kiełbiński, Marek;
- Zawilska, Krystyna;
- Kłoczko, Janusz;
- Wrzesień-Kuś, Agata
Publication type:
Article
Stanowisko Grupy Ekspertów, Towarzystw Naukowych i Konsultantów Krajowych w sprawie stosowania heparyn drobnocząsteczkowych we wskazaniach nieujętych w charakterystyce produktu leczniczego.
Published in:
Acta Angiologica, 2012, v. 18, n. 4, p. 128
By:
- Urbanek, Tomasz;
- Krasiński, Zbigniew;
- Dębski, Romuald;
- Kłoczko, Janusz;
- Marczyński, Wojciech;
- Pruszczyk, Piotr;
- Tomkowski, Witold;
- Undas, Aneta;
- Windyga, Jerzy;
- Zawilska, Krystyna
Publication type:
Article
Inhibitory proteasomów w terapii onkologicznej.
Published in:
Advances in Hygiene & Experimental Medicine / Postepy Higieny i Medycyny Doswiadczalnej, 2015, v. 69, p. 1443
By:
- Romaniuk, Wioletta;
- Ołdziej, Agnieszka Ewa;
- Zińczuk, Justyna;
- Kłoczko, Janusz
Publication type:
Article
The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 405, doi. 10.1016/j.clml.2021.11.012
By:
- Sacha, Tomasz;
- Szczepanek, Elzbieta;
- Dumnicka, Paulina;
- Gôra-Tybor, Joanna;
- Niesiobedzka-Krezel, Joanna;
- Prejzner, Witold;
- Wasilewska, Ewa;
- Kloczko, Janusz;
- Ciepluch, Hanna;
- Makowska, Wioletta;
- Patkowska, Elzbieta;
- Wasilewska, Joanna;
- Bober, Grazyna;
- Kopera, Malgorzata;
- Wichary, Ryszard;
- Kroll-Balcerzak, Renata;
- Gromek, Tomasz;
- Wach, Malgorzata;
- Rudkowska-Kazanowska, Anna;
- Swiniarska, Magdalena
Publication type:
Article
Anemia in cancer patients.
Published in:
Acta Haematologica Polonica, 2021, v. 52, n. 4, p. 397, doi. 10.5603/AHP.2021.0074
By:
- Bolkun, Lukasz;
- Kloczko, Janusz
Publication type:
Article
Anemia in cancer patients.
Published in:
Acta Haematologica Polonica, 2021, v. 52, n. 4, p. 397, doi. 10.5603/AHP.2021.0074
By:
- Bolkun, Lukasz;
- Kloczko, Janusz
Publication type:
Article
Plasma Factor XIII and some other Haemostasis Parameters in Patients with Diabetic Angiopathy.
Published in:
Acta Haematologica, 1986, v. 76, n. 2/3, p. 81, doi. 10.1159/000206026
By:
- Kłoczko, Janusz;
- Wojtukiewicz, Marek;
- Bielawiec, Míchat;
- Zarzycka, Barbara;
- Kinalska, Ida
Publication type:
Article
Relationship between tumour necrosis factor-related apoptosis inducing ligand (TRAIL) and vascular endothelial growth factor in human multiple myeloma patients.
Published in:
2015
By:
- Bolkun, Lukasz;
- Lemancewicz, Dorota;
- Piszcz, Jaroslaw;
- Moniuszko, Marcin;
- Bolkun‐Skornicka, Urszula;
- Szkiladz, Malgorzata;
- Jablonska, Ewa;
- Kloczko, Janusz;
- Dzieciol, Janusz
Publication type:
journal article
Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.
Published in:
American Journal of Hematology, 2017, v. 92, n. 4, p. 359, doi. 10.1002/ajh.24654
By:
- Pluta, Agnieszka;
- Robak, Tadeusz;
- Wrzesien-Kus, Agata;
- Katarzyna Budziszewska, Bozena;
- Sulek, Kazimierz;
- Wawrzyniak, Ewa;
- Czemerska, Magdalena;
- Zwolinska, Malgorzata;
- Golos, Aleksandra;
- Holowiecka-Goral, Aleksandra;
- Kyrcz-Krzemien, Slawomira;
- Piszcz, Jaroslaw;
- Kloczko, Janusz;
- Mordak-Domagala, Monika;
- Lange, Andrzej;
- Razny, Małgorzata;
- Madry, Krzysztof;
- Wiktor-Jedrzejczak, Wieslaw;
- Grosicki, Sebastian;
- Butrym, Aleksandra
Publication type:
Article
Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo- HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: A retrospective, multicenter Polish Adult Leukemia Group study.
Published in:
American Journal of Hematology, 2015, v. 90, n. 10, p. 904, doi. 10.1002/ajh.24113
By:
- Grosicki, Sebastian;
- Holowiecki, Jerzy;
- Kuliczkowski, Kazimierz;
- Skotnicki, Aleksander;
- Hellmann, Andrzej;
- Kyrcz-Krzemien, Slawomira;
- Dmoszynska, Anna;
- Sułek, Kazimierz;
- Kloczko, Janusz;
- Jedrzejczak, Wieslaw W.;
- Warzocha, Krzysztof;
- Zdziarska, Barbara;
- Wierzbowska, Agnieszka;
- Pluta, Agnieszka;
- Komarnicki, Mieczyslaw;
- Giebel, Sebastian
Publication type:
Article
Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL.
Published in:
Acta Oncologica, 2016, v. 55, n. 9/10, p. 1115, doi. 10.1080/0284186X.2016.1205217
By:
- Hillmen, Peter;
- Janssens, Ann;
- Babu, K. Govind;
- Kloczko, Janusz;
- Grosicki, Sebastian;
- Manson, Stephanie;
- McKeown, Astrid;
- Gupta, Ira;
- Chang, Chai-Ni;
- Offner, Fritz
Publication type:
Article
Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1–2 study.
Published in:
British Journal of Haematology, 2010, v. 150, n. 1, p. 58, doi. 10.1111/j.1365-2141.2010.08193.x
By:
- Coiffier, Bertrand;
- Losic, Nedjad;
- Rønn, Birgitte Biilmann;
- Lepretre, Stéphane;
- Pedersen, Lars Møller;
- Gadeberg, Ole;
- Frederiksen, Henrik;
- van Oers, Marinus H. J.;
- Wooldridge, James;
- Kloczko, Janusz;
- Holowiecki, Jerzy;
- Hellmann, Andrzej;
- Walewski, Jan;
- Robak, Tadeusz;
- Petersen, Jørgen
Publication type:
Article
Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production.
Published in:
British Journal of Haematology, 2003, v. 122, n. 3, p. 386, doi. 10.1046/j.1365-2141.2003.04439.x
By:
- Cazzola, Mario;
- Beguin, Yves;
- Kloczko, Janusz;
- Spicka, Ivan;
- Coiffier, Bertrand
Publication type:
Article
Prognostic significance of PD-1 expression on peripheral blood CD4+ T cells in patients with newly diagnosed chronic lymphocytic leukemia.
Published in:
Polish Archives of Internal Medicine, 2015, v. 125, n. 7/8, p. 553, doi. 10.20452/pamw.2967
By:
- Rusak, Małgorzata;
- Eljaszewicz, Andrzej;
- Bołkun, Łukasz;
- Łuksza, Ewa;
- Łapuć, Izabela;
- Piszcz, Jarosław;
- Singh, Paulina;
- Dąbrowska, Milena;
- Bodzenta-Łukaszyk, Anna;
- Kłoczko, Janusz;
- Moniuszko, Marcin
Publication type:
Article
Secondary acute lymphoblastic leukaemia in a multiple myeloma patient.
Published in:
Contemporary Oncology / Współczesna Onkologia, 2012, v. 16, n. 6, p. 593, doi. 10.5114/wo.2012.32497
By:
- Piszcz, Jaroslaw;
- Bolkun, Lukasz;
- Cichocka, Edyta;
- Kloczko, Janusz
Publication type:
Article
Plasma Concentrations of Protein Z and Protein Z-Dependent Protease Inhibitor in Patients With Essential Thrombocythemia.
Published in:
Clinical & Applied Thrombosis/Hemostasis, 2016, v. 22, n. 7, p. 679, doi. 10.1177/1076029615576741
By:
- Szumowska, Anna;
- Galar, Marzenna;
- Bolkun, Lukasz;
- Kloczko, Janusz
Publication type:
Article
Protein Z Concentrations in Patients With Acute Leukemia.
Published in:
Clinical & Applied Thrombosis/Hemostasis, 2012, v. 18, n. 5, p. 542, doi. 10.1177/1076029611429784
By:
- Galar, Marzenna;
- Piszcz, Jaroslaw;
- Bolkun, Lukasz;
- Szumowska, Anna;
- Kloczko, Janusz
Publication type:
Article
Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48970-0
By:
- Bolkun, Lukasz;
- Pienkowski, Tomasz;
- Sieminska, Julia;
- Godzien, Joanna;
- Pietrowska, Karolina;
- Kłoczko, Janusz;
- Wierzbowska, Agnieszka;
- Moniuszko, Marcin;
- Ratajczak, Mariusz;
- Kretowski, Adam;
- Ciborowski, Michal
Publication type:
Article
Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
Published in:
Oncology Reports, 2015, v. 34, n. 3, p. 1269, doi. 10.3892/or.2015.4088
By:
- LAPUC, IZABELA;
- BOLKUN, LUKASZ;
- ELJASZEWICZ, ANDRZEJ;
- RUSAK, MALGORZATA;
- LUKSZA, EWA;
- SINGH, PAULINA;
- MIKLASZ, PAULA;
- PISZCZ, JAROSLAW;
- ZYNSKA-KOPCZYNSKA, KATAR ZYNA PTAS;
- JASIEWICZ, MALGORZATA;
- KAMINSKI, KAROL;
- DABROWSKA, MILENA;
- BODZENTA-LUKASZYK, ANNA;
- KLOCZKO, JANUSZ;
- MONIUSZKO, MARCIN
Publication type:
Article

Found: 32

Utility of laboratory tests in B-CLL patients in different clinical stages.

Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.

Very Small Embryonic-Like Stem Cells, Endothelial Progenitor Cells, and Different Monocyte Subsets Are Effectively Mobilized in Acute Lymphoblastic Leukemia Patients after G-CSF Treatment.

The levels of sMUC-1 in patients with multiple myeloma.

Assessment of expression of selected Bcl-2 family proteins in lymphoid infiltration in patients with B-cell chronic lymphocytic leukaemia treated with nucleoside analogues.

A five‐year follow‐up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial.

A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial.

Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.

High chymotrypsin-like activity in the plasma of patients with newly diagnosed multiple myeloma treated with bortezomib is predictive of a better response and longer PFS.

The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age.

Prognostic relevance of HSP70 antigen and antibody measurement in patients with acute myeloid leukemia of intermediate and unfavorable cytogenetic risk.

Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG ‐ CLL4 (ML21283) trial.

Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil - follow-up of PALG- CLL randomized trials.

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group

Stanowisko Grupy Ekspertów, Towarzystw Naukowych i Konsultantów Krajowych w sprawie stosowania heparyn drobnocząsteczkowych we wskazaniach nieujętych w charakterystyce produktu leczniczego.

Inhibitory proteasomów w terapii onkologicznej.

The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program.

Anemia in cancer patients.

Anemia in cancer patients.

Plasma Factor XIII and some other Haemostasis Parameters in Patients with Diabetic Angiopathy.

Relationship between tumour necrosis factor-related apoptosis inducing ligand (TRAIL) and vascular endothelial growth factor in human multiple myeloma patients.

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo- HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: A retrospective, multicenter Polish Adult Leukemia Group study.

Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL.

Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1–2 study.

Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production.

Prognostic significance of PD-1 expression on peripheral blood CD4<sup>+</sup> T cells in patients with newly diagnosed chronic lymphocytic leukemia.

Secondary acute lymphoblastic leukaemia in a multiple myeloma patient.

Plasma Concentrations of Protein Z and Protein Z-Dependent Protease Inhibitor in Patients With Essential Thrombocythemia.

Protein Z Concentrations in Patients With Acute Leukemia.

Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy.

Circulating classical CD14<sup>++</sup>CD16<sup>-</sup> monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.